text:
Tony Castillo seeks Election to Woodville City Council Place 1
Tyler County Booster - March 2009
My name is Tony Castillo and I am announcing my candidacy for position 1 of the Woodville City Council. The citizens of Woodville are familiar with me. I was elected to the City Council in 2005 and held that office for a year until I became Mayor of Woodville in 2006. I ran for re-election as Mayor in 2008 and was narrowly defeated by the current Mayor. Because I was not re-elected I have had to wait a year to file for another position in city government. I have seen and been part of the city's growth over the past few years and I believe I am the best candidate for this position. I am married to Melissa and we have three children, Nathan 14, Madison 13, and Garrett 8. We moved to Woodville in 2001 and currently live at 505 Kirby Dr. I was the Administrator for Sinclair Childrens' Center for seven years. In 2008 I was hired by Girls' Haven, Inc., in Beaumont, to be the Executive Director and continue to serve in that position. I grew up in a small town in Louisiana called Converse. Converse has a population of approximately 450, so, I am definitely acclimated to the small town values. After graduating from high school in 1975, I attended East Texas Baptist University on a basketball scholarship. I completed my athletic career in 1979 and moved to Oklahoma where I obtained a Bachelor of Science in education from Southeastern Oklahoma State University in 1981. Currently, I am a Licensed Child Care Administrator, a Licensed Bachelor of Social Work, and a Certified Youth and Child Care Worker in the state of Texas. I have worked with children for 27 years as a teacher/coach in the public school system and in residential treatment for abused and neglected children. I have been active in community organizations and activities. While Mayor I represented Woodville on the Deep East Texas Council of Governments and served on the Grant Review Committee for DETCOG, I have participated in Entergy Team City, I am an Associate Member of the Woodville Lions Club and was President of the club in 2006, I am currently on the Board of Directors for Little Eagles Basketball, the Woodville Youth Football League, and have coached many years in Tyler County Little League baseball. My family and I are members of The Woodville United Methodist Church where I serve on several church committees. I have served on the Education Improvement Committee for the Woodville ISD, the Advisory Committee for the Retired Senior Volunteer Program, and the Tyler County Hazard Mitigation Task Force. Statewide, I have been President of the Texas Academy for Competent Youth Work, President of the Texas Youth and Child Care Workers Association, and served on the Board of Directors of the Child and Youth Care Worker Certification Institute of Texas. I have also held a position on theNational Board of Directors for the Association for Child and Youth Care Practice, Inc. As Councilman, I will bring to the Citizens of Woodville significant experience in local city government, the experience of serving on state and national boards of directors, as well as serving as President of those boards, with a strong sense of leadership and the ability to make decisions based on facts. I bring a strong business sense with experience of managing systems with sizable budgets, and am skilled with personnel/human resource matters. I believe a system with a sound infrastructure is a system that can grow and not become stagnant. I want to be a member of the Woodville City Council because this is where my children will grow up and I want them to have the best community possible to enable them to achieve their greatest potential. I want to be part of positive change and not sit back complaining about things expecting others to make the changes. I believe with my experience and strong belief in family and community values I will be an asset to the City of Woodville as a member of the City Council. Early voting will be April 27th – May 5th and the general election will be May 9,2009. Please vote for Tony Castillo for City Council Position 1.
Polk County Publishing Company
Copyright 2009
Contact Us: email@example.com
Call us at - (936) 327-4357
Webmaster: Gregg Faith


text:
Miami Heat v Charlotte Bobcats
Kemba Walker of the Charlotte Bobcats shoots against Mike Miller of... NyhetsfotoAmerikanska proffsligan i basket,Basketboll,Charlotte - North Carolina,Charlotte Hornets,Kemba Walker,Korgkast,Miami Heat - Basketlag,Mike Miller,North Carolina - Delstat,Slå ett slag - Sport,Sport,Time Warner Cable Arena,USA,VertikalPhotographer Kent SmithCollection: National Basketball Association 2013 NBAECHARLOTTE, NC - APRIL 5: Kemba Walker #15 of the Charlotte Bobcats shoots against Mike Miller #13 of the Miami Heat at the Time Warner Cable Arena on April 5, 2013 in Charlotte, North Carolina. NOTE TO USER: User expressly acknowledges and agrees that, by downloading and or using this photograph, User is consenting to the terms and conditions of the Getty Images License Agreement. Mandatory Copyright Notice: Copyright 2013 NBAE (Photo by Kent Smith/NBAE via Getty Images)

subset: commoncrawl


text:
Drag Coefficients, Drag Force Equations, Drag Force Calculation.
Register to enable "Calculate" button.
Click on the picture of the shape causing the drag. If the drag coefficient is independent of the geometry for the shape you clicked on, then the drag coefficient will appear without registering. After you register and enter your PIN into our home page, then the drag coefficient will appear for any shape and the calculation will be enabled for you to compute drag force or velocity.
If the applet does not look right, click the Refresh button at the top of your browser. Click on shape.
Units: cm=centimeter, cP=centipoise, cSt=centistoke, ft=feet, g=gram, hr=hour, kg=kilogram, lb=pound, m=meters, N=Newton, s=second
The drag force on an object is produced by the velocity of a liquid or gas approaching the object. Drag force is dependent upon the drag coefficient of the object and the geometry of the object. For some objects, the drag coefficient is independent of the object's dimensions. However, for other shapes of objects, the drag coefficient is dependent on the dimensions and may be additionally dependent on the Reynolds number. Our calculation has drag coefficients for a solid hemisphere, hollow hemisphere, solid cone, ellipsoid, annular disk, solid cylinder, solid cube, and solid square rod.
The drag force equation used for the calculation on this page is (Blevins, 2003 and Munson et al., 1998 and others):
F = 0.5 C ρA V2 Re = ρVD/μ
Area (A) is defined for each shape (Blevins, 2003):
For the solid hemispheres, hollow hemispheres, solid cone, ellipsoid, and solid cylinder, A = π D2 / 4.
For the solid cube and solid square rod, A = D2.
For the thin annular disk, A = π (Do2 - D2) / 4.
The drag coefficients (C) used in our calculation are from Blevins (2003). Drag coefficients for the solid hemisphere, hollow hemisphere, and cube are independent of dimensions or Reynolds number. The drag coefficient for the solid cone, ellipsoid, thin annular disk, solid cylinder, and solid square rod have drag coefficients that are functions of the shape's dimensions. Blevins (2003) provides tables of the drag coefficient versus dimensions. LMNO Engineering has fit equations to the Blevins tabular data with the resulting drag coefficient shown in the calculation above.
Our calculation allows you to use a variety of units with all of the conversions completed internally. The units shown below are SI (international system of units).
a = Angle in solid cone, radians.
A = Reference area (see figures above), m2.
C = Drag coefficient (see figures above), unitless.
D = Dimension shown in figures in applet, m.
Do = Outer dimension of annular disk as shown in figure in applet above, m.
F = Drag force, N.
L = Dimension shown in figures in applet, m.
Re = Reynolds number, unitless.
V = Velocity, m/s.
μ = Dynamic viscosity, N-s/m2 (same as kg/m-s).
ρ = Density of fluid (liquid or gas), kg/m3.
Messages given by calculation
Messages indicating input values are out of the acceptable ranges. Results will not be computed:
"Need Density > 0", "Need Viscosity > 0", "Need C > 0", "Need D > 0", "Must have D < Do", "Need Other dimension > 0", "Must have 10<=a<=180 deg", "Must have 1<=L/D<=10", "Need Velocity > 0", "Need Force > 0".
Run-time messages. Results will not be computed:
"Need Area > 0".
Warning messages. Results will be computed:
"C based on Re=170000" means that for this shape, the value of C is valid for a Reynolds number of 170000.
"C may not be valid for Re > 2E6" means that for this shape, C is valid for a certain range of Reynolds number.
Blevins, Robert D. 2003. Applied Fluid Dynamics Handbook. Krieger Publishing Co.
Munson, Bruce R., Donald F. Young, and Theodore H. Okiishi. 1998. Fundamentals of Fluid Mechanics. John Wiley and Sons, Inc. 3ed.
© 2008 LMNO Engineering, Research, and Software, Ltd. (All Rights Reserved)
LMNO Engineering, Research, and Software, Ltd.
7860 Angel Ridge Rd. Athens, Ohio 45701 USA (740) 592-1890
firstname.lastname@example.com http://www.LMNOeng.com


text:
A recent Wednesday, 8:56 p.m.: If drinking cheap beer and rolling Skee-Ball were an Olympic sport, the participants of the San Francisco chapter of Brewskee-Ball would be contenders for a medal.
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|1
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|2
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|3
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|4
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|5
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|6
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|7
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|8
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|9
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|10
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|11
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|12
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|13
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|14
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|15
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|16
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|17
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|18
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|19
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|20
- gallery_thumbnails_photo|cityexposed-2421-post-2498-g25238|cityexposed-2421-post-2498-g25238|21
Inside the Buckshot Bar and Gameroom in the Inner Richmond, the antlered animal heads on the wall dimly visible in the red light, cans of Pabst Blue Ribbon and Tecate litter the table next to two classic Skee-Ball machines. Players on the sidelines shout and slap high-fives when their teammates roll high scores, and commiserate with more drinks when they don't.
When it's their turn to roll, the players step forward with a game face and a strategy.
"I'm not superstitious! I think superstition is bad luck," said Brian Roundy, 30, who has been watching his friends hone their techniques for the past year at the Buckshot. "But people certainly have their little routines that they do. Some roll left foot forward – some right foot forward. Some hold three (balls) at a time, some just one."
Representing a team called the Foxskee Ladies, Chris "Liza Minnellskee" Morrell, 31, always takes a ceremonial sip from his beer before he rolls. His teammate Shannon "SKZA" Finley, 27, twirls the ball in her right hand before each roll. Rick "Skeethulu" Kitagawa, 30, braces his shin on the front of the machine hard enough to leave a bruise as he holds each ball gingerly at the end of his fingertips, as if it were some kind of offering to the Skee-Ball gods.
Alison Sickelka, 29, stretches before holding the fist-sized ball out in front of her. Every single time.
"I consider Alison the Ken Griffey Jr. of Brewskee-Ball, because she's left-handed and it's an absolutely beautiful stroke," Roundy said. "It's like watching Griffey swing for the fences."
Three nights a week, a total of 32 teams with names like the Lionel Richskees and the Skeemosexuals compete against each other at the Buckshot. At the end of the eight-week skeeson, the top 24 compete in the local Brewskee mug tournament.
Once a year, the most elite rollers duke it out at the Brewskee-Ball national championship. The last one was held in Austin, Texas, where 64 players competed for the top prize of $3,000 and the coveted "cream jacket." The top 16 teams from around the country also compete for the right to drink from a 32-ounce crystal mug that the winner holds onto until the next championship.
"This goal of the game is to have fun while rolling Skee-Ball with people who are similarly enthusiastic about this particular game," Morrell said. "The bar provides a sanctuary to sort of be a family."
Brewskee-Ball was created in New York by Eric Pavony in 2005 after he and a work colleague had a hankering to play Skee-Ball. The only machines to be found were at the end of an hour-and-a-half train ride to Coney Island. After a day of friendly competition, they came up with the idea for a league.
Nearly 10 years later, Pavony, now 34, presides over the national Brewskee-Ball league, with chapters in Brooklyn, N.Y.; Austin; Wilmington, N.C.; and San Francisco. The beer drinking isn't in the rulebook, but then, chewing tobacco isn't a requirement for playing Major League Baseball.
"We were the first people to really think about what makes a Skee-Ball player good," Pavony said. "Up until that time, people pretty much arbitrarily rolled balls up the lanes."
That may be, but there have been plenty of amateur enthusiasts since a man named J.D. Estes created the Skee-Ball machine more than 100 years ago. For years it was a staple of amusement parks, and machines can still be found at the Santa Cruz Beach Boardwalk.
For the uninitiated, Skee-Ball is kind of a cross between bowling and horseshoes. Players get nine balls to roll up an 18-inch-wide alley, about 10 feet long, to a launching point called the ball hop. The ball flies toward holes of increasing values, with the hardest to reach being worth the most points. In Brewskee-Ball, the final score of the night is recorded after 10 rounds of play.
Pavony, who owns a Skee-Ball-centric bar in Brooklyn, once rolled a perfect game, 900 points, in 2007. He has a YouTube video to prove it.
Though the crystal mug matters to some, most play Brewskee-Ball for the glory of the game, the camaraderie, the beer.
"I do it because I love it. I'm addicted to it," said Stephanie "Tigerrr" Brand, 26, a nanny and children's camp director by day who rolls for the Foxskee Ladies. "It's my favorite thing in the world."
for daily updates follow @cityexposed


text:
We offer discount to nonprofits, government agencies, and federal contractors
Recently the handling of civil immigration detainers by local law departments has been heavily scrutinized.
AILA Doc No. 08031433 | Dated March 14, 2008 | File Size: 24 KDownload the Document
On 3/14/08 USCIS released an Update from Director Emilio Gonzalez on processing times for naturalization applications.
[[To print the PDF on this page please use the print function in the PDF reader.]]
Cite as AILA Doc. No. 08031433.Open the Document
American Immigration Lawyers Association
1331 G Street NW, Suite 300
Washington, DC 20005
Copyright © 1993-2015
American Immigration Lawyers Association.


text:
Tampa, Florida -- Tampa Mayor Bob Buckhorn is cracking down on poorly kept properties this week.
The City has developed a concentrated task force for the next 30 days to identify properties that are an eyesore and hazardous to the community. Officials warned property owners with a 21-day notice to clean up their lot or in 21 days they will be back with a $75 city fine.
District Supervisor Susan Wenrick said she already reported dozens of warnings on Sunday and saw an immediate response from neighbors.
"They started to get rid of their piles of trash and debris on their lawns right away," said Wenrick. "It is like the 'Broken Window' theory, but in reverse. The theory where one broken window leads to more broken windows -- well, I want the reverse to happen. More neighbors painting their homes, cleaning their lawns and planting flowers starts to spread to other neighbors."
Mayor Buckhorn said he will continue to monitor neighborhoods that are known for illegal dumping after the 30-day task force effort ends. He said the challenge is the foreclosed properties that are banked owned.
"There are 6,000 registered foreclosed properties, not all of them are in violation, but those that are in violation are difficult to monitor because the banks only pay a fee for us to come by and clean them instead of us writing a citation to a property owner directly who has to clean his or her property," Wenrick said.


text:
42 U.S. Code § 16133 - State grant, rebate, and loan programs
(a) In general
Subject to the availability of adequate appropriations, the Administrator shall use 30 percent of the funds made available for a fiscal year under this part to support grant, rebate, and loan programs administered by States that are designed to achieve significant reductions in diesel emissions.
(b) Applications
The Administrator shall—
(1) provide to States guidance for use in applying for grant, rebate, or loan funds under this section, including information regarding—
(2) establish, for applications described in paragraph (1)—
(c) Allocation of funds
(1) In general
For each fiscal year, the Administrator shall allocate among States for which applications are approved by the Administrator under subsection (b)(2)(B) funds made available to carry out this section for the fiscal year.
(2) Allocation
(A) In general
Except as provided in subparagraphs (B) and (C), using not more than 20 percent of the funds made available to carry out this part for a fiscal year, the Administrator shall provide to each State qualified for an allocation for the fiscal year an allocation equal to 1/53 of the funds made available for that fiscal year for distribution to States under this paragraph.
(B) Certain territories
(i) In general Except as provided in clause (ii), Guam, the United States Virgin Islands, American Samoa, and the Commonwealth of the Northern Mariana Islands shall collectively receive an allocation equal to 1/53 of the funds made available for that fiscal year for distribution to States under this subsection, divided equally among those 4 States.
(C) Reallocation
If any State does not qualify for an allocation under this paragraph, the share of funds otherwise allocated for that State under this paragraph shall be reallocated to each remaining qualified State in an amount equal to the product obtained by multiplying—
(i) the proportion that the population of the State bears to the population of all States described in paragraph (1); by
(3) State matching incentive
(A) In general
If a State agrees to match the allocation provided to the State under paragraph (2) for a fiscal year, the Administrator shall provide to the State for the fiscal year an additional amount equal to 50 percent of the allocation of the State under paragraph (2).
(4) Unclaimed funds
Any funds that are not claimed by a State for a fiscal year under this subsection shall be used to carry out section 16132 of this title.
(d) Administration
(1) In general
Subject to paragraphs (2) and (3) and, to the extent practicable, the priority areas listed in section 16132 (c)(3) of this title, a State shall use any funds provided under this section to develop and implement such grant, rebate, and low-cost revolving loan programs in the State as are appropriate to meet State needs and goals relating to the reduction of diesel emissions.
(2) Apportionment of funds
The chief executive of a State that receives funding under this section may determine the portion of funds to be provided as grants, rebates, or loans.
(3) Use of funds
A grant, rebate, or loan provided under this section shall be used for a project relating to—
(4) Priority
(5) Public notification
Not later than 60 days after the date of the award of a grant, rebate, or loan by a State, the State shall publish on the Web site of the State—
(A) for rebates, grants, and loans provided to the owner of a diesel vehicle or fleet, the total number and dollar amount of rebates, grants, or loans provided, as well as a breakdown of the technologies funded through the rebates, grants, or loans; and
Source(Pub. L. 109–58, title VII, § 793,Aug. 8, 2005, 119 Stat. 841; Pub. L. 110–255, § 3(b),June 30, 2008, 122 Stat. 2424; Pub. L. 111–364, § 2(c),Jan. 4, 2011, 124 Stat. 4059.)
2011—Pub. L. 111–364, § 2(c)(1), inserted ", rebate," after "grant" in section catchline.
Subsec. (a). Pub. L. 111–364, § 2(c)(2), inserted ", rebate," after "grant".
Subsec. (b)(1). Pub. L. 111–364, § 2(c)(3), inserted ", rebate," after "grant" in introductory provisions.
Subsec. (c)(2). Pub. L. 111–364, § 2(c)(4), amended par. (2) generally. Prior to amendment, par. (2) related to allocation of funds.
Subsec. (d)(1). Pub. L. 111–364, § 2(c)(5)(A), inserted ", rebate," after "grant".
Subsec. (d)(2). Pub. L. 111–364, § 2(c)(5)(B), inserted ", rebates," after "grants".
Subsec. (d)(3). Pub. L. 111–364, § 2(c)(5)(C), substituted "grant, rebate, or loan provided under this section shall be used" for "grant or loan provided under this section may be used" in introductory provisions.
Subsec. (d)(4), (5). Pub. L. 111–364, § 2(c)(5)(D), added pars. (4) and (5).
2008—Subsec. (c)(2)(A). Pub. L. 110–255, § 3(b)(2), substituted "51" for "50" and "1.96 percent" for "2 percent".
Subsec. (c)(2)(B). Pub. L. 110–255, § 3(b)(2), substituted "51" for "50" in introductory provisions.
Subsec. (c)(2)(B)(ii). Pub. L. 110–255, § 3(b)(2), which directed substitution of "1.96 percent" for "2 percent", was executed by making the substitution for "2-percent", to reflect the probable intent of Congress.
Subsec. (d)(2). Pub. L. 110–255, § 3(b)(1), substituted "chief executive" for "Governor".
Effective Date of 2011 Amendment
Amendment by Pub. L. 111–364effective Oct. 1, 2011, except that amendment by section 2(c)(4) ofPub. L. 111–364effective Jan. 4, 2011, see section 4 ofPub. L. 111–364, set out as a note under section 16131 of this title.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.


text:
So sorry, but only 4 items are allowed for comparison. I blame the gnomes and so should you.
Would you like to compare the products you have selected now?
So sorry, but this item is sold out.
You probably would've looked amazing with it too.
We do have some similar items available right now though.
Check out Mens Running ShoesView Other Similar Stuff
The Vibram FiveFingers Speed shoes are inspired by the comfort and performance of the popular FiveFingers Bikila, and designed for the casual barefoot shoe wearer. The FiveFingers Speed feature a traditional lacing system and are built to comfortably accommodate an array of foot widths and instep heights. The super breathable upper with flex zones provides a secure and comfortable fit, and the 4mm Vibram sole offers awesome grip on a variety of surfaces. These Vibram FiveFingers are designed for more casual use, and are ideal for feet recovering after sport and outdoor activities, or sticking with barefoot shoes when traveling.
Getting the right size and style of FiveFingers is supes important to making your venture into barefoot fitness a success. Check out our Vibram FiveFingers info page to watch some videos, learn how to size your feet for FiveFingers, and find which FiveFingers are best for which activities.
|Footwear Features:
Free Shipping
Spend $12 in Moosejaw products OR at least $49
in other products and you orders ships FREE!
Moosejaw Rewards
You earn $1 in Rewards for every $10 you spend
at Moosejaw.com and our shops (half for discounted items).


text:
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
|No Recent Quote currently available
My Portfolio Tracker
One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.
|Company Name
Jan 16, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Watson Pharmaceuticals Inc (NYSE:WPI), Barrick Gold Corp (NYSE:ABX), Brookfield Infrastructure Partners LP (NYSE:BIP), Dow Chemical Co (NYSE:DOW), Honda Motor Co Ltd (NYSE:HMC) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Thursday:
Symbol Company # of Reports Quarter Release Date
WPI Watson Pharmaceuticals Inc 6 Quarter Q4 02/14/2013
ABX Barrick Gold Corp February Earnings Q4 02/14/2013
BIP Brookfield Infrastructure Partners LP 6 Quarter Q4 02/08/2013
DOW Dow Chemical Co 6 Quarter Q4 01/31/2013
HMC Honda Motor Co Ltd 12 Quarter Q3 01/31/2013
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Watson Pharmaceuticals Inc (NYSE:WPI) - Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products in the United States, western Europe, Canada, Australasia, Asia, South America, and South Africa. The company offers its products for therapeutic categories, such as central nervous system, cardiovascular, hormones and synthetic substitutes, anti-infective agents, and urology. It operates in three segments: Global Generics, Global Brands, and Distribution. The Global Generics segment develops, manufactures, and sells generic pharmaceutical products, as well as distributes generic versions of third parties brand products. This segment offers various dosage forms, such as oral solids, transdermals, injectables, inhalation products, and transmucosals for indications, including pregnancy prevention, pain management, depression, hypertension, and smoking cessation. The Global Brands segment promotes and co-promotes Rapaflo, Gelnique, Trelstar, Androderm, Crinone, ella, INFeD, Generess, sodium ferric gluconate, AndroGel, and Femring branded products; and markets its products through sales professionals. It also sells various non-promoted products. The Distribution segment distributes generic and select brand pharmaceutical products, vaccines, injectables, and over-the-counter medicines to independent pharmacies, alternate care providers, pharmacy chains, and physicians offices. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. Watson Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Parsippany, New Jersey..
Barrick Gold Corp (NYSE:ABX) - Barrick Gold Corporation engages in the production and sale of gold and copper. The company has a portfolio of 27 operating mines, and exploration and development projects located in North America, South America, the Australia Pacific region, and Africa. It also holds interests in oil and gas properties located in Canada. Barrick Gold Corporation was founded in 1983 and is headquartered in Toronto, Canada..
Brookfield Infrastructure Partners LP (NYSE:BIP) - Brookfield Infrastructure Partners L.P. engages in the utilities, transportation and energy, and timber businesses. The company operates a port facility that exports metallurgical and thermal coal mined in the central Bowen Basin region of Queensland, Australia; approximately 8,800 kilometers of electricity transmission lines in North and South America; and approximately 1.5 million electricity and natural gas connections in the United Kingdom, New Zealand, and Colombia. It also provides transportation, storage, and handling services for energy, freight, bulk commodities, and passengers; operates a rail service with approximately 5,100 kilometers of tracks in southwestern Western Australia; approximately 30 port terminals primarily in Europe; 15,500 kilometers of natural gas transmission lines primarily in the United States; and engages in the toll road operation businesses. In addition, the company engages in the timber businesses and operates approximately 419,000 net acres of freehold timberlands located in the coastal region of British Columbia, Canada; and the Pacific Northwest region of the United States. Brookfield Infrastructure Partners Limited serves as a general partner of Brookfield Infrastructure Partners L.P. The company was founded in 2007 and is based in Hamilton, Bermuda. Brookfield Infrastructure Partners L.P. is a subsidiary of Brookfield Asset Management Inc..
Dow Chemical Co (NYSE:DOW) - The Dow Chemical Company manufactures and supplies chemical products used as raw materials in the manufacture of customer products and services worldwide. Its Electronic and Functional Materials segment offers materials for chemical mechanical planarization, chemical processing aids and intermediates, electronic displays, food and pharmaceutical processing and ingredients, home and personal care ingredients, hygiene and infection control, photolithography, printed circuit boards, process and materials preservation, semiconductor packaging, and electronic and industrial finishing. The company s Coatings and Infrastructure Solutions segment provides construction chemical solutions and building-integrated photovoltaics; raw materials for architectural paints and industrial coatings; technologies for water purification, desalination, and separation solutions; and specialty monomer products. Its Agricultural Sciences segment offers agricultural crop protection and plant biotechnology products, pest management solutions, and seeds, traits, and oils. The company s Performance Materials segment produces ethanolamines, ethyleneamines, isopropanolamines, and chelants; chlorinated organic products; polyurethane foams and systems; epoxy resins and intermediates; oxygenated solvents; polyglycols and surfactants; and polyurethane raw materials. Its Performance Plastics segment offers performance elastomers and plastomers, specialty copolymers, and synthetic rubber; semiconductive and insulation material for power cable insulation; sticking and bonding solutions and specialty films; polyethylene-based solutions; and polypropylene products. The company s Feedstocks and Energy segment provides caustic soda, chlorine, ethylene dichloride, hydrochloric acid, and vinyl chloride monomer; ethylene oxide and ethylene glycol; and benzene, butadiene, butylene, cumene, ethylene, octane, propylene, and styrene. The Dow Chemical Company was founded in 1897 and is based in Midland, Michigan..
Honda Motor Co Ltd (NYSE:HMC) - Honda Motor Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of motorcycles, automobiles, and power products worldwide. Its motorcycle line consists of business and commuter models, as well as sports models, including trial and moto-cross racing; all terrain vehicles; and multi utility vehicles. The company also produces various automobile products, including passenger cars, light trucks, and mini vehicles; and power products comprising tillers, portable generators, general-purpose engines, grass cutters, outboard marine engines, water pumps, snow throwers, power carriers, power sprayers, lawn mowers and lawn tractors, and home-use cogeneration units, as well as thin film solar cells for home, public, and industrial uses. In addition, it sells spare parts and provides after sales services through retail dealers; and offers retail lending and leasing to customers, as well as wholesale financing to dealers. The company was founded in 1946 and is headquartered in Tokyo, Japan..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
CONTACT: Buyins.net Thomas Ronk email@example.com www.buyins.net
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com.
As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated an UPTREND on
05-24-2012 for ABX @ $39.66.
As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated an UPTREND on
10-10-2011 for BIP @ $24.81.
As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated an UPTREND on
05-29-2012 for DOW @ $31.83.
For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com
SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2015 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.


text:
<< Go Back
Q: I would like to purchase furniture as a gift, what are my options?
A: When purchasing furniture as a gift, remember comfort is subjective. What may be comfortable for you may not be for someone else. La-Z-Boy Incorporated produces many different styles of furniture to meet the various needs of our consumers. You may wish to purchase a gift certificate from a local dealer in the recipient's area. Gift certificates are not transferable, so it is important to purchase the certificate from a dealership near them. This allows the recipient to choose a style to fit his or her needs. In addition, their dealer will be in close proximity should their furniture require service. To locate an authorized dealer, please visit the Store Locator on this website.
Join our email list and be the first to hear about new products, the latest trends and styles, along with so much more.


text:
Rollover image for closeup
Thirty Days to Music IntervalsItem #: HL.09970591
Our Price:
Unrated ( Be the first to review this item )
by Hal Leonard
Composed by Audrey Snyder.
Lessons and Reproducible Activities for the Music Classroom. Expressive Art (Choral). Voicing/Format: TEACHER ED. 8.5x11 inches. 64 pages. Published by Hal Leonard. (HL.09970591)
Free Shipping on this item in orders above $199
In Stock
Found in: Children's Choral Lessons, Children's Choral Sheet Music
From the popular Thirty Days series, here is another publication for teaching basic music concepts. These self-guided lessons and ready-to-use reproducible activity sheets are ideal for choir, band, general music class and orchestra. Each of the thirty lessons in this book is presented in a logical sequence, and will help students learn to recognize all types of intervals through both sight and sound. Throughout the series of flexible lessons, students are given ample opportunity to sing and play the whole array of intervals, and develop their musicianship by identifying intervals within the context of melodies. Whether presented as a comprehensive unit, or stretched throughout the entire semester or year, the lessons can be used for whole group, small group or individual study, saving valuable class time for rehearsal and other activities. Enhance your study with activities from Thirty Days to Music Theory, Thirty Days to Rhythm and Thirty Days to Melody. For Gr. 4-8.


text:
JBL VRX900 SeriesPortable loudspeakers rank high. 4/01/2008 8:00 AM Eastern
JBL VRX900 Series
Apr 1, 2008 12:00 PM, By John McJunkin
Portable loudspeakers rank high.
It seems like every manufacturer in the world is making a powered speaker-on-a-stick solution these days, and many of them really do the trick for portable sound reinforcement. But there are certain applications for which a pair of plastic potato-shaped boxes just won't do the trick. And sure, you could get into stacks of boxes in order to achieve high quality, but then portability suffers. Is there a middle-of-the-road solution? There is indeed.
The JBL Professional VRX series loudspeakers have been available for a couple of years, and the company has recently introduced powered versions of this series, further enhancing portability. I test-drove a system consisting of two VRX918SP subwoofers, each supporting two VRX932LAP boxes. Frankly, I was thrilled.
The VRX932LAP is similar to other line-array loudspeakers, with one notable exception — we've grown accustomed to seeing symmetrical LF drivers on either side of the HF array in the middle of the box. Shave off one of those LF drivers, and you have the VRX932LAP. It employs the JBL Constant Curvature Line Array waveguide, which acoustically couples three HF drivers per box on a single line. When multiple boxes are used, the waveguide creates a continuous arc and keeps the distance between drivers equal — thus creating a constant curvature line source. Up to five boxes can be employed, and with vertical coverage of 15 degrees per box, a total of 75 degrees can be covered vertically. The horizontal coverage is 100 degrees wide.
One particularly unexpected feature is the ability to optimize coverage with the system's Array Configuration Selector (ACS), which is an amplitude shading mechanism. It allows you to either boost or cut each individual box's HF output (above approximately 1.5kHz) by 3dB — attenuating the HF output from the bottom loudspeakers closest to the front row of the audience — while simultaneously increasing HF output from the topmost boxes, dispersing more energy to the back of the room. Pretty clever and advanced for this type of system.
The other particularly clever feature of these loudspeakers is their integral rigging hardware, which facilitates the mechanical coupling of loudspeakers with hinged metal bars that are held in place with quick-release pins. JBL makes a line-array frame available, which along with the loudspeaker's built-in rigging hardware and dual-angle pole-mount socket, create a nice range of suspension options.
The VRX918SP is an ordinary subwoofer in appearance, roughly cube-shaped, with a healthy metal grille. It features the Drivepack DPC-2, developed in cooperation with Crown International. The "2" in the DPC-2 designation refers to Dual-Bridged Technology, the unique use of two discrete amplifiers to drive the two discrete voice-coils of the JBL Differential Drive woofer, maximizing power efficiency.
I can tell you that this mechanism provides full, round low end, but not just a pile of SPL — you can actually distinguish what kind of bass you're hearing. This subwoofer has a top-mounted receptacle intended to receive a SS4BK adjustable satellite-speaker pole. It can be used on the floor or flown with JBL line-array hardware. In addition to the previously mentioned ACS controls, the VRX932LAP has power and signal I/O; an attenuation knob; and peak, power, and signal indicator LEDs found on both subwoofer and MF/HF boxes. The VRX918SP's panel has crossover selector buttons that toggle insertion of the internal HF and determine its cutoff frequency to be either 80Hz or 120Hz.
I test-drove the system provided by JBL Professional in an application that included a male speaker, live music, and some multi-media. Again, I had a pair of VRX918SP subwoofers and each supported two VRX932LAPs.
Load-in and setup was really a two-person job, considering the size and weight of the subs. Additionally, once two VRX932LAPs are connected together with JBL's clever mechanism, you wind up with a pretty hefty construct, considering there are two 12in. LF drivers, amplifiers, and six HF drivers.
Actually, this rig is not all that heavy, but it still requires two people to hoist it onto the stand. Nevertheless, it sounds like a system that requires a full crew for load-in and setup. Connections were quite simple — feeding balanced line-level signals from front-of-house into the subs, which then fed the high-pass-filtered signal on to the other two daisy-chained boxes. JBL Professional has chosen to use Neutrik PowerCon connectors to get AC power to the amplifiers. In my mind, their similarity to Speakon audio connectors is a potential source for confusion, but as long as all technicians involved are aware of this, it shouldn't be a problem.
The application in which I test-drove the system normally uses a pair of JBL EON 15s, so I knew that the VRX rig would clearly deliver a lot more SPL. Otherwise, I simply fed the same unequalized (and lightly compressed) signal from FOH directly to the system.
The stereo image was the first thing to knock my socks off. Obviously, with its sophisticated waveguide and highly controlled dispersion pattern, left and right are very clearly delineated. Spectrally speaking, the entire audible spectrum was all there — and I do mean all there. The 18in. subwoofers are rated to 34Hz, and that's not an exaggeration. The LF drivers in the VRX932LAP boxes handled the low-mids and mids very nicely — and with two per side in this system, there was no strain in doing so. The HF drivers probably impressed me the most. The highs were crisp and clean, but not brittle.
In addition to the music and speech program material I heard, I also took the liberty of listening to a broad spectrum of music from CD as well — all great recordings. Rock fared very well, as did jazz, but the dynamic range of classical music really exposed the strength of this system. I listened to an excellent recording of Holst's The Planets at some pretty substantial SPLs, and considering my familiarity with that particular recording, I was truly blown away with the reproduction. These loudspeakers are not in the same league as JBL's Vertec series, but they stand on stilts head and shoulders above any other speaker-on-a-stick solution I've ever heard.
These loudspeakers deliver incredibly high quality considering their portability. They also facilitate some unexpectedly powerful means for sculpting the output for the environment. When factoring in price, it becomes pretty obvious that this system is well worth consideration. Indeed, if you need both high quality and portability, I haven't heard a better system.
Company: JBL Professional www.jblprofessional.com
Product: VRX900 series
Pros: Excellent balance of high quality with portability.
Cons: Speakon AC power scheme could be confusing.
Price: $3,199 (VRX932LAP); $2,249 (VRX918SP)
Frequency response: 75Hz to 20kHz (±3dB
Coverage pattern: 100×15 degrees
Maximum peak output: 136dB SPL at M
Internal amp output: 1750W peak, 875W continuous
System management: DSP limiters, mechanical/thermal protection
Dimensions: 13.75"×23.5"×17.5"
Weight: 52lbs.
Frequency response: 34Hz to 120Hz (±3dB)
Maximum peak output: 126dB SPL at M
Internal amp putput: 1500W peak, 750W continuous
System management: DSP limiters, mechanical/thermal protection
Dimensions: 20"×23.5"×29.5"
Weight: 85lbs.
John McJunkin is the principal of Avalon Podcasting in Chandler, Ariz. He has consulted in the development of studios and installations, and he provides high-quality podcast-production services.
Get our Free Newsletter Here!


text:
Browning Cross Country Upland Shirt for Men - Long Sleeve
Browning's® light, super-comfortable, easy-care 100% polyester fabric transports moisture away from your skin. Features include a quilted shoulder with REACTAR™ pocket (pad sold separately) and an angled chest pocket for quick access. Color: Khaki/ Blaze. Machine wash. Imported.
- Fabric transports moisture away from your skin
- Quilted shoulder with REACTAR™ pocket
- Angled chest pocket for quick access
Manufacturer model #: 301193.
Browning® REACTAR™ G2 Pad sold separately and can be found through item search for item number 38-867-431-02
Outdoor Answers
Get help about this item from fellow customers.
Ask your questions. Share your answers.
Do they make these for left handed shooters?
Need Help? 7 days a week: 7am to 10pm CT or call 1.800.227.7776 anytime


text:
|Publication number
|Publication type
|Application number
|Publication date
|Dec 6, 2001
|Filing date
|Jul 6, 2001
|Priority date
|Jun 22, 1998
|Also published as
|Publication number
|Richard Fulton, William Dubrul
|Original Assignee
|Artemis Medical, Inc.
|Export Citation
|BiBTeX, EndNote, RefMan
|Patent Citations (1), Referenced by (38), Classifications (16), Legal Events (11)
|External Links: USPTO, USPTO Assignment, Espacenet
[0001] This application claims the benefit of the following Provisional patent applications. Biopsy Localization Device, Application No. 60/090,243, filed Jun. 22, 1998; Biopsy Localization and Hemostasis Device, Application No. 60/092,734, filed Jul. 14, 1998; Device and Method of Biopsy Localization and Hemostasis, Application No. 60/114,863, filed Jan. 6, 1999; and Device and Method of Biopsy Localization, Hemostasis & Cancer Therapy, Application No. 60/117,421, filed Jan. 25, 1999.
[0002] In the U.S. alone approximately one million women will have breast biopsies because of irregular mammograms and palpable abnormalities. See FIG. 1 which diagrams the current treatment algorithm for non-palpable breast lesions. Biopsies can be done in a number of different ways for non-palpable lesions, including surgical excisional biopsies and stereotactic and ultrasound guided needle breast biopsies. In the case of image directed biopsy, the radiologist or other physician takes a small sample of the irregular tissue for laboratory analysis. If the biopsy proves to be malignant, additional surgery (typically a lumpectomy or a mastectomy) is required. The patient then returns to the radiologist a day or two later where the biopsy site (the site of the lesion) is relocated by method called needle localization, a preoperative localization in preparation for the surgery.
[0003] Locating the previously biopsied area after surgical excision type of biopsy is usually not a problem because of the deformity caused by the surgery. However, if the biopsy had been done with an image directed needle technique, as is common, help in relocating the biopsy site is usually needed. One procedure to permit the biopsy site to be relocated by the radiologist during preoperative localization is to leave some of the suspicious calcifications; this has its drawbacks.
[0004] Another way to help the radiologist relocate the biopsy site involves the use of a small metallic surgical clip, such as those made by Biopsys. The metallic clip can be deployed through the biopsy needle, and is left at the biopsy site at the time of the original biopsy. With the metallic clip as a guide, the radiologist typically inserts a barbed or hooked wire, such as the Hawkins, Kopans, Homer, Sadowski, and other needles, back into the patient's breast and positions the tip of the wire at the biopsy site using mammography to document the placement. The patient is then taken to the operating room with the needle apparatus sticking out of the patient's breast. While the clip provides a good indication of the biopsy site to the radiologist during preoperative localization, the clip remains permanently within the 80% of patients with benign diagnoses. Also, because the clip is necessarily attached to a single position at the periphery of the biopsy site, rather than the center of the biopsy site, its location may provide a misleading indication of the location of diseased tissue during any subsequent medical intervention. In addition, the soft nature of breast tissue permits the tip of the barbed or hooked needle to be relatively easily dislodged from the biopsy site. The clip is also relatively expensive.
[0005] Another localization method involves the use of laser light from the tip of a optical fiber connected to a laser. A pair of hooks at the tip of the optical fiber secures the tip at the biopsy site; the glow indicates the position of the tip through several centimeters of breast tissue. This procedure suffers from some of the same problems associated with the use of barbed or hooked wires. Another preoperative localization procedure injects medical-grade powdered carbon suspension from the lesion to the skin surface. This procedure also has certain problems, including the creation of discontinuities along the carbon trail.
[0006] The present invention is directed to a biopsy localization method and device which uses a locatable bioabsorbable element left at the biopsy site so that if testing of the biopsy sample indicates a need to do so, the biopsy site can be relocated by finding the bioabsorbable element. This eliminates the need to use of metallic clips during biopsies and often eliminates the need for a return to the radiologist for preoperative needle localization. In addition, the bioabsorbable element can be used as a therapeutic tool for treatment of the diseased lesion and for hemostasis.
[0007] A biopsy localization device made according to the invention includes a bioabsorbable element delivered in a pre-delivery state to a soft tissue biopsy site of a patient by an element delivery device. The bioabsorbable element may be palpably harder than the surrounding soft tissue at the biopsy site when in the post-delivery state.
[0008] One preferred material used as the bioabsorbable element is a dehydrated collagen plug. This type of plug may swell and is palpable for subsequent location by the surgeon. The collagen plug may not swell at all. In some situations, such as with small breasted women or where the biopsy site is close to the surface, a non-swellable bioabsorbable material, such as a round pellet of PGA, can be used instead of a swellable bioabsorbable material. The bioabsorbable material can also be made so that it is absorbed quickly to produce a local tissue inflammation; such a localized inflammation can be used to locate the biopsy site instead of location by palpation. Instead of leaving, for example, a collagen plug, a PGA pellet or a bioabsorbable suture material at the biopsy site for location by palpation or inflammation, a length of bioabsorbable suture material, a collagen filament, or other bioabsorbable material extending from the biopsy site out through the skin can be used. In this case the surgeon can follow the bioabsorbable suture material to the biopsy site in a manner similar to that used with Hawkins needles. In other cases, such as in the case of a deeply located lesion or large breast, the bioabsorbable material may need to be located by the radiologist, by for example, ultrasound or mammography. In any event the bioabsorbable material will typically be absorbed within about a month of placement. The invention thus eliminates the use of metal clips during biopsies and usually eliminates the need for return to the radiologist for preoperative localization.
[0009] While the primary use of the device is intended to localize the site of needle biopsies for possible future surgical excision, the device may also be useful in marking the site of surgical excisional biopsies. For example, during a wide surgical excision for cancer diagnosed by a recent surgical excisional biopsy, surgeons frequently have difficulty in determining the precise relationship of the previously excised tissue to the surgical wound. Therefore, more tissue is removed than might have been removed had the exact location of the previous lesion been more definite. With the present invention, a bioabsorbable element may be inserted into the biopsy site during a surgical excisional biopsy before the wound is closed to mark the site for potential wide excision should the biopsy reveal cancer. Alternatively, a bioabsorbable element may be placed at the biopsy site using a delivery device by partially or completely closing the wound and then depositing the bioabsorbable element through the delivery device and removing the delivery device through the closed incision. The presence of the palpable marker within the previous excisional biopsy site would allow the surgeon to more easily and confidently remove tissue around this site, and preserve more normal breast tissue.
[0010] Another use of the device is to primarily localize a non-palpable lesion prior to surgical excisional biopsy. Instead of using the needle/wire apparatus which has a tendency to migrate and become dislodged with traction, the palpable marker may be inserted into the suspicious area of the breast under mammographic or ultrasonic guidance immediately prior to the surgical excisional biopsy. This would provide a palpable locator for the surgeon as described above. In this instance, the marker would only need to be palpable, and not necessarily bioresorbable, since the intent would be to remove it in all cases.
[0011] In addition to permitting the biopsy site to be located by subsequent palpation or other means, the invention also can provide hemostasis and therapeutic benefits. Since the bioabsorbability can be varied from a day or two to a year or more, the material may be used to treat the diseased tissue and not just locate it. Some current therapies include radiation, chemotherapy, gene therapy as well as other technologies and therapies. Because the bioabsorbability can be easily varied, a medium can be place into the bioabsorbable element and be externally excited or triggered in those cases where the biopsy results are malignant. Further, the bioabsorbability concept can be used for future implantation of a therapeutic agent. For example, if the bioabsorbable element is a dehydrated collagen, this material could be used as a reservoir for, for example, delivery of materials that effect chemotherapy, brachytherapy, etc. Once the laboratory results are received and show the biopsy is malignant and therapy is required, by surgical excision or otherwise, the physician may inject, for example, a radiation pellet, a chemotherapeutic agent or a gene therapeutic agent into or adjacent to the bioabsorbable element for direct treatment of the diseased tissue.
[0012] The change in the bioabsorbable element can be via one of several ways, such as hydration or desiccation, change in temperature, electrical stimulation, magnetic stimulation, chemical or physical reaction with another material, additives, enzymatic reactions, ionization, electrical charges, absorption, as well as other means. The invention may employ one or more of these techniques or measures or others, to change the consistency, hardness and or size of the bioabsorbable element between its deployed and non-deployed states. The visual detectability of the bioabsorbable element may be aided by the use of a coloring agent, such as methylene blue or some other dye. The Radiographic detectability of the element may be enhanced by a radiopaque marker. As well, ultrasonic detectability may be enhance by special treatment of the bioresorbable element.
[0013] The bioresorbable element may have margins which are roughened so as to prevent migration within the tissues. Filaments extending from the margins of the bioresorbable element may be utilized also to stabilize the position of the device within the cavity. The filaments may or may not be composed of the same material as the bioresorbable element.
[0014] The provision of hemostasis helps to lessen the bleeding and swelling within and about the biopsy site. This can be accomplished by physical or chemical means. That is, the device may swell so that it essential fills the biopsy cavity or the device may have a chemical reaction with blood or blood products to cause effective blood clotting, or both. Other methods for causing local hemostasis are also possible with the invention.
[0015] Other features and advantages of the invention will appear from the following description in which the preferred embodiments and methods have been set forth in detail in conjunction with the accompany drawings.
[0016]FIG. 1 is a flow diagram of a conventional treatment algorithm for nonpalpable breast lesions;
[0017]FIG. 2 is a flow diagram of a treatment algorithm according to the present invention;
[0018]FIG. 3 is a simplified view illustrating a biopsy needle assembly obtaining a tissue sample of an abnormality at a target site;
[0019]FIG. 4 illustrates the main housing and sheath of the needle biopsy assembly left in place after the tissue sample has been removed leaving a biopsied open region at the target site;
[0020]FIG. 5 illustrates the barrel of the delivery device of FIG. 4 inserted into the main housing of the biopsy needle assembly and the plunger depressed injecting the bioabsorbable element into the biopsied open region, thus effectively filling the biopsied open region at the target site;
[0021]FIG. 6 illustrates the location of the bioabsorbable element of FIG. 5 with the surgeon using his or her fingers; and
[0022]FIG. 7 illustrates a bioabsorbable thread extending from the bioabsorbable element of FIG. 5 up through the patient's skin, the thread being delivered to the bioabsorbable element using the delivery device of FIGS. 4 and 5.
[0023]FIG. 2 illustrates a treatment algorithm 2 according to the present invention. As a result of a routine mammography 4, a tumor or other abnormality may be detected as at 6. The typical response will often include additional magnification mammograms or a follow-up mammogram scheduled for some time in the future, such as six months. This is indicated at 8. If the tumor is not palpable, see 9, an image guided needle biopsy by a breast radiologist is typically conducted as at 10. Image guided needle biopsies can be done in a number of ways. Presently, stereotactic (x-ray) and ultrasound guided needle biopsies are commonly used, primarily because of their accuracy, speed and minimal trauma to the patient. Stereotactic needle biopsies typically use a stereotactic table, such as made by Fisher or Lorad, which provides mammography (x-ray) guidance to a biopsy needle assembly. Ultrasound guided biopsies can be conducted with any one of a number of commercially available instruments. An exemplary biopsy needle assembly 14, illustrated in FIG. 3, includes a biopsy needle 13 passing through a sheath 20 extending from a hollow main housing 22. The tip 12 of biopsy needle 13 of biopsy needle assembly 14 is automatically inserted to the abnormality 16 at the target site 18. Biopsy needle 13 has a laterally directed side opening 24 adjacent to tip 12 used to capture a tissue sample of abnormality 16. Once the tissue samples have been obtained, the removed tissue creates a biopsied open region 26 at target site 18. See FIG. 4. Following the removal of biopsy needle 13 from sheath 20 and main housing 22, the barrel 30 of a bioabsorbable element delivery device 32 is inserted through main housing 22 and into sheath 20. Barrel 30 contains a bioabsorbable element 34, see FIG. 5 Bioabsorbable element 34 is, in this preferred embodiment, a plug of dehydrated collagen, such as that sold by several companies such as Davol, Datascope, Integra Life Sciences, Collagen Matrix, Vascular Solutions, et al. Bioabsorbable element 34 may swell on contact with an aqueous liquid within biopsied open region 26 and substantially fills the biopsied open region as suggested in FIG. 5. In this preferred embodiment, bioabsorbable element 34 is transformed from its pre-delivery state within barrel 30 to its post-delivery state at region 26 and in the process swells and becomes somewhat softer in its post-delivery state than in its pre-delivery state. However, in its post-delivery state, bioabsorbable element 34 is palpably harder, preferably at least about 1.5 times harder, than the surrounding soft tissue, typically breast tissue 36. This permits bioabsorbable element 34 at the target site 18 to be relocated by palpation of the patient by the physician, see FIG. 6, to find the bioabsorbable element 6 and as discussed in more detail below.
[0024] A bioabsorbable element could be made of materials other than collagen and could be in a form other than a solid, relatively hard plug in its pre-delivery state. For example, bioabsorbable element 34 in its pre-delivery state within barrel 30 could be in a liquid or otherwise flowable form; after being deposited at open region 26 at target site 18, the bioabsorbable element could change to become palpably harder than the surrounding tissue 36 to permit subsequent relocation of target site 18 by palpation. In some situations, it may be desired that bioabsorbable element 34 not change its size or hardness between its pre-delivery state and its post-delivery state, such as being palpably harder than the surrounding tissue 36 in both states. In a preferred embodiment, transformation of bioabsorbable element 34 is by contact with an aqueous liquid.
[0025] However, transformation of the bioabsorbable element, which can be in terms of, for example, hardness, texture, shape, size, or a combination thereof, can be due to other factors, such as application of thermal energy, radiation, magnetic energy, etc.
[0026] Returning again to FIG. 2, it is seen that after insertion of bioabsorbable element 34, the biopsy sample is sent to pathology for evaluation at 36. If the pathology report, which is available a day or two after the biopsy, is benign, the patient is so informed and the bioabsorbable element simply is absorbed by the patient within, for example, a month as at 38. If the pathology report is positive, so that cancer is found, the biopsied open region 26 at the target site 18 is located by the surgeon by palpation as suggested by FIG. 6. After finding the target site by palpation, which eliminates the need for preoperative localization by the radiologist, appropriate medical treatment, such as excisional surgery, can be performed.
[0027] If the tumor is palpable, the surgeon may choose to make a direct incisional biopsy as at 48. According to the present invention, bioabsorbable delivery device 32 could be used to place bioabsorbable element 34 at the site of the incisional biopsy. After removal of delivery device 32, the incision would be closed, the biopsy sample would be sent to pathology and the patient would go home with the procedure preceding as discussed above, starting with item 36.
[0028] It may be preferred that bioabsorbable element 34 also act as a hemostatic agent to stop bleeding at site 18 by virtue of physical means, by filling or substantially filling open region 26, as well as chemical means through the chemical interaction, such as coagulation, with blood components. In addition, bioabsorbable element 34 could be covered by a non-hemostatic degradable outer layer so that hemostasis or other action is delayed until the outer layer has been eroded. In some situations, it may be necessary or at least desirable to shield the bioabsorbable element from the blood or other body fluids until after the bioabsorbable element is in place at target site 18. This could be accomplished by, for example, physically isolating the bioabsorbable element from body fluids by using a removable physical barrier during delivery of the bioabsorbable element. Alternatively, a bioabsorbable coating or layer, as described above, may be used. The bioabsorbable element may be changed from its pre-delivery state to its post-delivery state in a variety of manners including hydration, changing the temperature, electrical stimulation, magnetic stimulation, chemical reaction with a stimulating agent, physically interaction with an activating member (such as a knife blade which could be used to slice open a capsule containing the bioabsorbable element), by ionizing the bioabsorbable element, or by absorption or adsorption of a fluid by the bioabsorbable element.
[0029] The invention may also be used to medically treat the patient. That is, the bioabsorbable element-could include a therapeutic element which would be activated only if the pathology report indicated the need for the medical treatment. Various ways of activating an agent in a bioabsorbable element could be used, such as injecting a radiation-emitting element at the vicinity of the target site, externally irradiating the target site, providing a triggering substance to the target site, manual pressure, photodynamic therapy, sclerosing chemistry, vibrational therapy, ultrasound, and the like. Alternatively, the bioabsorbable element could be made so that it includes no such activating agent; rather, medical treatment could be provided by, for example, delivery of a chemotherapy agent, a radiation emitting element, thermal energy, electrical energy, vibrational energy, gene therapy, vector therapy, anti-angiogenesis therapy. To facilitate the delivery, the bioabsorbable element may contain a radiopaque marker or may have properties to aid in detecting it by ultrasound, in addition to being palpable.
[0030] An important use for the invention is in the treatment of breast cancer. In one embodiment, it is desirable that bioabsorbable element 34 in its post-delivery state have a hardness of at least about one and a half times that of breast tissue so that it is palpably harder than the surrounding tissue. Also, it is desired that bioabsorbable element 34, in one embodiment, swells from its pre-delivery state to its post-delivery state so to fill or at least substantially fills open region 26. To achieve this it is preferred that bioabsorbable element 34 swells about 50 to 1500%, and more preferably about 100 to 300%, from the pre-delivery state to the post delivery state, typically when placed in contact with an aqueous liquid. It is preferred that the bioabsorbable element has a longest dimension of at least about 0.5 cm in its post-delivery state to aid its location by palpation.
[0031] While the bioabsorbable element is preferably made of collagen in one embodiment, the bioabsorbable element can include, for example, one or more of the following materials; polyactic and polyglycolic acids, polyorthoesters, resorbable silicones and urethanes, lipids, polysaccharides, starches, ceramics, polyamino acids, proteins, hydrogels and other gels, gelatins, polymers, cellulose, elastin, and the like.
[0032] In some situations it may be desired to use a bioabsorbable filament 44 extending from bioabsorbable element 34 through the patient's skin 46 as shown in FIG. 7. This can be accomplished by delivering bioabsorbable filament 44 through sheath 20 as bioabsorbable element 34 is injected into region 26 at target site 18. In some situations it may not be possible or desirable to use bioabsorbable element 34; in those situations it may be useful to provide for only bioabsorbable filament 44 extending from target site 18 to above the patient's skin 46.
[0033] While it is presently preferred that bioabsorbable element delivery device 32 be guided through a portion of needle assembly 14, that is sheath 20 and main housing 22, in some situations it may be useful to cover sheath 20 with an outer sheath which would be left in place after the biopsy sample has been removed and the entire biopsy needle assembly 14 has been removed. The sheath left in place would then be used to guide barrel 30 of delivery device 32 to target site 18. Of course, delivery device 32 could take a number of different forms such as a syringe containing fluid or paste that is injected through a needle or through the housing 22 and sheath 20 or through an outer sheath. Alternatively, other delivery devices could be employed for delivery of bioresorbable element 34.
[0034] The invention has applicability toward the correction of a defect that is caused by breast tissue removal for biopsy or diseased tissue removal. Collagen is often placed in the body where it is eventually replaced by human autogenous tissue. Hence, the invention could be used for the repair of tissue that has been damaged due to tissue removal. The delivery device described heretofore could be used for installing a material (synthetic or mammalian) into the cavity for such a cosmetic or reconstructive repair. The material would typically be an effectively non-bioabsorable material, such as a silicon gel-filled capsule or bag.
[0035] Modification and variation can be made to the disclosed embodiments without departing from the subject of the invention as defined in the following claims.
[0036] Any and all patents, patent applications, and printed publications referred to above are incorporated by reference.
|Cited Patent
|Filing date
|Publication date
|Dec 2, 1997
|May 15, 2001
|Imarx Pharmaceutical Corp.
|Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|Citing Patent
|Filing date
|Publication date
|Feb 27, 2002
|May 20, 2003
|Senorx, Inc.
|Methods and chemical preparations for time-limited marking of biopsy sites
|Oct 31, 2001
|Dec 9, 2003
|Senorx, Inc.
|Imageable biopsy site marker
|Nov 20, 2000
|Apr 20, 2004
|Senorx, Inc.
|Tissue site markers for in VIVO imaging
|Apr 16, 2002
|Mar 1, 2005
|Senorx, Inc.
|Cavity-filling biopsy site markers
|Apr 12, 2004
|Jan 31, 2006
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Nov 21, 2003
|Feb 7, 2006
|Senorx, Inc.
|Imageable biopsy site marker
|Sep 10, 2003
|May 16, 2006
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Sep 29, 2005
|Jul 21, 2009
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Jun 17, 2002
|Jan 26, 2010
|Senorx, Inc.
|Plugged tip delivery for marker placement
|Nov 16, 2004
|Sep 7, 2010
|Senorx, Inc.
|Cavity-filling biopsy site markers
|May 23, 2003
|Jan 25, 2011
|Senorx, Inc.
|Marker or filler forming fluid
|Jun 18, 2008
|Jun 28, 2011
|Senorx, Inc.
|Marker delivery device with releasable plug
|May 23, 2003
|Jul 19, 2011
|Senorx, Inc.
|Fibrous marker and intracorporeal delivery thereof
|Nov 18, 2009
|May 15, 2012
|Senorx, Inc.
|Plugged tip delivery tube for marker placement
|Jul 10, 2012
|Senorx, Inc.
|Cavity-filling biopsy site markers
|Jul 13, 2009
|Jul 17, 2012
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Mar 1, 2011
|Jan 29, 2013
|Senorx, Inc.
|Marker delivery device with releasable plug
|Dec 14, 2010
|May 21, 2013
|Senorx, Inc.
|Marker or filler forming fluid
|Apr 8, 2011
|Jul 30, 2013
|Senorx, Inc.
|Intracorporeal marker and marker delivery device
|Jun 8, 2011
|Jan 7, 2014
|Senorx, Inc.
|Fibrous marker and intracorporeal delivery thereof
|Jun 13, 2012
|Jan 7, 2014
|Senorx, Inc.
|Cavity-filling biopsy site markers
|May 16, 2013
|Jan 28, 2014
|Senorx, Inc.
|Marker or filler forming fluid
|May 25, 2010
|May 6, 2014
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Apr 27, 2012
|Jul 22, 2014
|Senorx, Inc.
|Plugged tip delivery tube for marker placement
|Jul 19, 2013
|Nov 4, 2014
|Senorx, Inc.
|Fibrous marker and intracorporeal delivery thereof
|Dec 6, 2013
|Feb 24, 2015
|Senorx, Inc.
|Cavity filling biopsy site markers
|Jan 25, 2013
|Jun 2, 2015
|Senorx, Inc.
|Marker delivery device with releasable plug
|Jun 17, 2002
|Dec 18, 2003
|Senorx, Inc.
|Plugged tip delivery tube for marker placement
|Nov 21, 2003
|Jun 17, 2004
|Senorx, Inc.
|Biopsy site marker and process and apparatus for applying it
|Apr 12, 2004
|Sep 30, 2004
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|May 23, 2003
|Nov 25, 2004
|Senorx, Inc.
|Fibrous marker and intracorporeal delivery thereof
|Jul 25, 2003
|Feb 10, 2005
|Klein Dean A.
|Multi-modality marking material and method
|Sep 10, 2003
|Mar 24, 2005
|Senorx, Inc.
|Tissue site markers for in vivo imaging
|Mar 26, 2004
|Oct 20, 2005
|Beckman Andrew T
|Apparatus and method for marking tissue
|Jan 27, 2006
|Jun 8, 2006
|Senorx, Inc.
|Imageable biopsy site marker
|Mar 2, 2006
|Jul 13, 2006
|Senorx, Inc.
|Imageable biopsy site marker
|Dec 8, 2011
|Malignext Targeting Technologies, Inc.
|Tissue Marking for Lesion Removal
|Jun 7, 2011
|Dec 15, 2011
|Malignext Targeting Technologies, Inc.
|Tissue marking for lesion removal
|U.S. Classification
|International Classification
|Cooperative Classification
|European Classification
|Jun 8, 2004
|Request for reexamination filed
Effective date: 20040426
|May 31, 2005
|Request for reexamination filed
Effective date: 20050408
|Jul 5, 2005
|Reexamination certificate first reexamination
Free format text: THE PATENTABILITY OF CLAIMS 1-10 IS CONFIRMED.
|Aug 29, 2007
|Fee payment
Year of fee payment: 4
|Oct 16, 2007
|Reexamination certificate second reexamination
Free format text: THE PATENTABILITY OF CLAIMS 1-10 IS CONFIRMED. NEW CLAIMS 11-29 ARE ADDED AND DETERMINED TO BE PATENTABLE.
|Apr 8, 2008
|Request for reexamination filed
Effective date: 20080117
|Jul 13, 2010
Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA
Free format text: SECURITY AGREEMENT;ASSIGNOR:ARTEMIS MEDICAL, INC.;REEL/FRAME:024672/0377
Effective date: 20100709
|Dec 6, 2010
Owner name: DEVICOR MEDICAL PRODUCTS, INC., OHIO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ARTEMIS MEDICAL, INC.;REEL/FRAME:025456/0694
Effective date: 20101206
|Sep 2, 2011
|Fee payment
Year of fee payment: 8
|Aug 14, 2012
|Reexamination certificate third or further reexamination
Free format text: CLAIMS 1-7, 9-17, 19-26, 28 AND 29 ARE CANCELLED. CLAIMS 8, 18 AND 27 WERE NOT REEXAMINED.
|Sep 1, 2015
|Fee payment
Year of fee payment: 12


text:
Enjoy the benefits
Training and accredition program
Version 2.0, 24hr Solo Championships Expression of Interest Bid Guide for 2015 and 16. (20th January, 2015)
Presented at the 2013 Our Sporting Future conference, Melbourne
Launched at 2013 Our Sporting Future - Melbourne
In response to the Australian Government's reply to the Wood review of Cycling CA have called for volunteers to add to the expertise at Board and other levels.
This is the Australian Government's response to Justice Wood's review of Cycling in Australia in the wake of the Lance Armstrong doping admissions.
The review of Cycling conducted in Late 2012 by Justice Wood in response to the Lance Armstrong allegations and Australian rider confessions on Drugs in Sport
MTBA's consitution after the Special Meeting held on 8th December 2012
UCI points for Australian C2, CN and CC International Events
The 2013 UCI Rules and regulations that come into force 1st january 2013
Message from MTBA president re the delay in the 2012 Special Resolutions and AGM
IMBA Australia Trail Difficulty Rating System guidelines for land managers and trail users. This download is very useful for trail planners and designers in providing physical dimensions for trail features and obstacles when developing new trails and assessing existing trails.
The agreed strategic plan for MTBA till 2016. This will provide a framework for clubs seeking funding through the Club Grant Scheme.
Cycling Australia is one of 12 other major sporting bodies to sign up to the federal Government's Anti binge drinking initiative.
The UCI calculations for nations to field athletes at the 2012 London Olympics.
The roles and responsibilities for committee members are described in this file.
Use this form to secure a expo, support or team/club site at a round in the 2011-2012 National Series.
Get ConnectedFollow @MTBAust


text:
H.R.3302 - Restore America Act of 2011
To create private sector jobs by simplifying the tax code, increasing domestic energy production, reforming government regulations, and strengthening workforce training programs. view all titles (2)
All Bill Titles
- Official: To create private sector jobs by simplifying the tax code, increasing domestic energy production, reforming government regulations, and strengthening workforce training programs. as introduced.
- Short: Restore America Act of 2011 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 1
- Past Seven Days: 16
- All-Time: 3,966
RepresentativeThomas Rooney
Official SummaryRestore America Act of 2011 - Deems the Draft Proposed Outer Continental Shelf (OCS) Oil and Gas Leasing Program 2010-2015 to have been approved by the Secretary of the Interior as a final oil and gas leasing program in full compliance with specified environmental and other applicable laws.
Official SummaryRestore America Act of 2011 - Deems the Draft Proposed Outer Continental Shelf (OCS) Oil and Gas Leasing Program 2010-2015 to have been approved by the Secretary of the Interior as a final oil and gas leasing program in full compliance with specified environmental and other applicable laws. Directs the Secretary to conduct a lease sale every 270 days in each OCS area for which the Secretary determinates there is a commercial interest in purchasing federal oil and gas leases for production on the OCS (OCS Planning Area). Amends the Outer Continental Shelf Lands Act to:
(1) provide for the sharing of of OCS receipts from the leasing of tracts within a specified number of miles of a state coastline;
(2) direct the Secretary to include, in each 5-Year Program, lease sale proposals for at least 75% of the available unleased acreage within each OCS Planning Area; and
(3) require coordination with adjacent states for pipeline construction for crude oil, petroleum products, and natural gas. Prohibits, on either federal OCS or state waters, uses that are incompatible with:
(1) oil and gas leasing, and
(2) full oil or natural gas exploration and production on tracts that are geologically prospective for oil and/or natural gas. Requires the Secretary to accept, in satisfaction of mitigation requirements, proposals for mitigation measures on a site away from the area impacted by exploration and production activities. Directs the Secretary to establish and implement a competitive oil and gas leasing program for the exploration, development, and production of the oil and gas resources on the Coastal Plain of Alaska. Amends the Alaska National Interest Lands Conservation Act to repeal the prohibition against leasing or other development leading to production of oil and gas from the Arctic National Wildlife Refuge. Authorizes the Secretary to designate up to 45,000 acres of the Coastal Plain as a Special Area, after consultation with the state of Alaska, the city of Kaktovik, and the North Slope Borough. Prescribes procedures, terms, and conditions for Coastal Plain lease sales,, including regarding:
(1) environmental protection,
(2) federal and state distribution of revenues,
(3) rights-of-way, and
(4) local government impact aid and community service assistance. Sets forth:
(1) a \"no significant adverse effect\" standard to govern Coastal Plain activities, and
(2) guidelines for expedited judicial review of complaints. Establishes in the Treasury the Coastal Plain Local Government Impact Aid Assistance Fund. Authorizes the Secretary to use amounts in such Fund to provide timely financial assistance to Alaska communities that are directly impacted by oil and gas exploration or production on the Coastal Plain and to establish a coordination office by the North Slope Borough in Kaktovik. Requires the Secretary to hold a lease sale to offer an additional 10 parcels for lease for research, development, and demonstration of oil shale resources. Authorizes the Secretary to temporarily reduce royalties, fees, rentals, bonus bids, or other payments for leases of federal lands for the development and production of oil shale resources. Repeals the limitation on the authority of a federal agency to contract for the procurement of alternative or synthetic fuels under the Energy Independence and Security Act of 2007. Requires the Nuclear Regulatory Commission (NRC) to:
(1) issue operating permits for 200 new commercial nuclear reactors by 2040, and
(2) establish and implement an expedited procedure for issuing a combined construction and operating license for nuclear reactors. Authorizes the NRC to provide an applicant for a nuclear reactor license a provisional certification of a proposed nuclear reactor design. Amends the Nuclear Waste Policy Act of 1982 to abolish the Office of Civilian Radioactive Waste Management. Requires the federal government to site and permit at least one radiological material geologic repository for the disposal of radiological material. Requires the Secretary of Energy (DOE) to:
(1) report to Congress on the feasibility of establishing an independent radiological material management program, and
(2) conduct an inventory of all DOE materials that could be used to power commercial nuclear reactors. Prohibits the President from blocking or hindering spent nuclear fuel recycling activities. Prohibits the Secretary of the Interior from preventing uranium mining on federal lands unless the Secretary makes findings explaining the reason for such prevention. Revises provisions relating to congressional review of agency rulemaking to require congressional approval of major rules before they may take effect. Revises the definition of \"major rule\" (generally a rule that is likely to result in an annual effect on the economy of $100 million or more) to include an interim final rule. Permits a major rule to take effect for one 90-day calendar period without such approval if the President determines such rule is necessary because of an imminent threat to health or safety or other emergency, for the enforcement of criminal laws, for national security, or to implement an international trade agreement. Sets forth House and Senate procedures for enacting joint resolutions approving major rules and disapproving non-major rules. Amends the Internal Revenue Code to:
(1) reduce the maximum corporate income tax rate to 25% on taxable income exceeding $50,000, and
(2) allow a permanent $500,000 expensing allowance for depreciable business assets. Makes permanent provisions of the Economic Growth and Tax Relief Reconciliation Act of 2001 that reduce capital gain and dividend tax rates and estate and gift taxation. Requires the House Committee on Ways and Means to prioritize the reporting of legislation that would:
(1) simplify the Internal Revenue Code,
(2) eliminate deductions that unjustly benefit corporations and special interests, and
(3) consider proposals that will disincentivize and eliminate tax shelters. Calls for Congress to reauthorize the Workforce Investment Act of 1998 to improve, expand, and modernize job training and other employment-related programs under such Act.
...Read the Rest
Latest Letters to Congress
H.R.3302 Restore America Act of 2011
November 21, 2011
I am writing as your constituent in the 6th Congressional district of Maryland. I support H.R.3302 - Restore America Act of 2011, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.


text:
Bill Gardner is OK with smoker discrimination:
Smoking is a vice that benefits no one. It's not a candidate for a lifestyle choice that we want to protect through employment laws.
Paul Kelleher counters.
(Photo: People smoke cigarettes outside of an office building in New York City. By Spencer Platt/Getty Images.)


text:
Your cart is empty!
Nutella is my favorite, I love this product. It is very tasty,Delicious. Fantastic spread for bread, toast, crackers, or as a topping on some other food items. Nutella is mind-bogglingly yummy.
I love this flavor of Soyjoy - Berry. I stock up in huge quantities. I take 2-3 of these to work and have one or two for breakfast and save one in case I need a snack. It is delicious - but it took some getting used to. It looks funny and almost appears overbaked on the bottom - but after you get past that - just enjoy. This is a fantastic product.
Super Colon Cleanse Dietary Fiber Supplement Capsules By Health Plus - 120 Ea
Our Price:$8.25
Nature Made Omega - 3 Fish Oil 1200 Mg Maximum Strength Softgels - 100 Ea
Our Price:$6.17
Nature Made Omega-3 Fish Oil 1200 Mg Odorless Softgels - 60 Ea
Our Price:$7.61
Centrum Specialist Multivitamin/Multivitamin Tablets For Heart - 60 Ea
Our Price:$11.25
Atkins Advantage Caramel Double Chocolate Crunch Bar - 5 Ea
Our Price:$7.21
Tilex Mold And Mildew Remover Spray, Contains Bleach - 32 Oz
Our Price:$4.25


text:
Video: 911 call released from sister-in-law of wrong-way driver
Tampa, Florida -- The Tampa Police Department has released another 911 call regarding the I-275 wrong-way crash, this time from the sister-in-law of driver Daniel Morris.
The calls came into the 911 center at 2:26 a.m. and 2:36 a.m., just after the crash took place and killed 5 people.
The woman starts by saying Morris was her brother-in- law and that he stole the car after "something went out of control." Later she says that Morris was more friend than brother-in-law and that they all had a few drinks.
She adds that Morris left a birthday party upset but she was unsure why. She says Morris recently moved from Detroit.
Related stories: